LAVA Therapeutics NV

CIK 1840748 · 172 filings in 43 form types · 2021-01-25 to 2025-12-16

Former names: LAVA Therapeutics BV

FiledFormCategory8-K items / descriptionAccession
2025-12-16 15-12G Other 0001104659-25-121581
2025-11-21 25-NSE/A Other 0001354457-25-001168
2025-11-21 SC TO-T/A Other 0001193125-25-290606
2025-11-21 S-8 POS Registrations and prospectuses 0001104659-25-114799
2025-11-21 S-8 POS Registrations and prospectuses 0001104659-25-114797
2025-11-21 SC 14D9/A Other 0001104659-25-114795
2025-11-21 8-K Current reports 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0001104659-25-114793
2025-11-17 4 Ownership 0001822092-25-000005
2025-11-17 4 Ownership 0001814695-25-000005
2025-11-17 4 Ownership 0001796398-25-000004
2025-11-17 4 Ownership 0001456849-25-000005
2025-11-17 4 Ownership 0001388000-25-000005
2025-11-17 4 Ownership 0001331339-25-000005
2025-11-17 4 Ownership 0001328146-25-000004
2025-11-17 4 Ownership 0001267490-25-000006
2025-11-17 4 Ownership 0001130637-25-000005
2025-11-13 SC TO-T/A Other 0001193125-25-278820
2025-11-13 SC 14D9/A Other 0001104659-25-110947
2025-11-13 8-K Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 9.01 Financial Statements and Exhibits 0001104659-25-110913
2025-11-10 SC 14D9/A Other 0001104659-25-109284
2025-11-07 8-K Current reports 5.07 Submission of Matters to a Vote of Security Holders 0001104659-25-108480
2025-11-06 10-Q Financial reports 10-Q 0001104659-25-107725
2025-10-22 SCHEDULE 13D/A Ownership 0001193125-25-246866
2025-10-20 4 Ownership 0001193125-25-243899
2025-10-17 SCHEDULE 13D/A Ownership 0001193125-25-242678
2025-10-17 SC TO-T/A Other 0001193125-25-242199
2025-10-17 DEFR14A Proxies 0001104659-25-100443
2025-10-17 SC 14D9/A Other 0001104659-25-100336
2025-10-17 DEFA14A Proxies 0001104659-25-100321
2025-10-17 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-25-100317
2025-10-15 4 Ownership 0001193125-25-240610
2025-10-14 SCHEDULE 13D/A Ownership 0001193125-25-239087
2025-10-10 4 Ownership 0001193125-25-237275
2025-10-02 SC TO-T/A Other 0001193125-25-228454
2025-10-02 SC 14D9/A Other 0001104659-25-096168
2025-10-02 DEFA14A Proxies 0001104659-25-096154
2025-10-02 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-25-096152
2025-09-30 DEFA14A Proxies 0001104659-25-094747
2025-09-30 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-25-094744
2025-09-26 SCHEDULE 13G Ownership 0001723643-25-000013
2025-09-23 SCHEDULE 13D/A Ownership 0001193125-25-213528
2025-09-23 4 Ownership 0001193125-25-213445
2025-09-18 SCHEDULE 13D/A Ownership 0001193125-25-207693
2025-09-18 4 Ownership 0001193125-25-207677
2025-09-09 SC TO-T/A Other 0001193125-25-199167
2025-09-03 SC TO-T/A Other 0001193125-25-195061
2025-09-03 CORRESP Other 0001104659-25-087126
2025-09-03 SC 14D9/A Other 0001104659-25-087123
2025-09-03 DEFM14A Proxies 0001104659-25-087113
2025-08-26 UPLOAD Other 0000000000-25-009108